The Patent Finder

Tanox Pharma B.V.

Also on record
Records under this name other than patents Tanox Pharma B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 3 of 3 · Back to Tanox Pharma B.V.

PatentTitleStatus Expires Confidence
US 7,479,552Type-1 ribosome-inactivating protein
Formerly held
Term ended
Term ended Mar 23, 2020 · From the USPTO record
Term endedTerm ended Mar 23, 2020From the USPTO record
US 6,680,296Type-1 ribosome-inactivating protein
Formerly held
Term ended
Term ended Mar 10, 2020 · From the USPTO record
Term endedTerm ended Mar 10, 2020From the USPTO record
US 6,645,494Anti-CD40L immunotoxins for the treatment of diseases
Formerly held
Lapsed on the fee record
Ended Nov 11, 2011 · From the USPTO record
Lapsed on the fee recordEnded Nov 11, 2011From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited